Research Article
GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use
| Attribute | Method of analysis | Acceptance criteria |
| Donor screening | Serology (antibody testing) | Negative for anti-HIV1, 2 anti-HCV, HBsAg, anti-HBc, syphilis, HTLV I/II | Nucleic acid amplification technique (NAT, antigen testing) | Negative for HIV, HBV, and HCV |
| Sterility | Bacteria/fungus: BACT/ALERT microbial detection system (aerobic and anaerobic) | Negative/negative | Bacterial endotoxin (LAL, method D) | <70 IU/ml | Mycoplasma (NAT) | Negative |
| Identity and purity | Flow cytometry | | | | | HLA- |
| ASC viability | Nucleocounter NC100 | >80% |
|
|